EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Clinical trial NCT00338247 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT00338247
Sponsor: Novartis
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Neoplasms, Breast

Start date: 2006-07-01
Primary completion: 2015-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.